Clinical Trials Browser

Asthma, Cystic Fibrosis, Lung Diseases, Pulmonary Fibrosis, Tuberous Sclerosis, Sarcoidosis, Pulmonary, alpha 1-Antitrypsin Deficiency

NCT00001465 2026-04-06

Study of the Disease Process of Lymphangioleiomyomatosis

Recruiting

2,000 enrolled

Lung Diseases, Pneumothorax, Tuberous Sclerosis, Lymphangioleiomyomatosis

NCT00366509 2021-08-02

Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases

Completed

157 enrolled

Asthma, Lung Diseases, Pulmonary Fibrosis, Sarcoidosis, Lymphangioleiomyomatosis, Genetic Diseases, Inborn

NCT00923520 2018-12-05

A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies

Phase 1 Completed

60 enrolled

BreastGastrointestinalGenitourinaryLymphoidThoracic

Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Lung Diseases, Lung Neoplasms, Lymphoma, Lymphoma, Non-Hodgkin, Neoplasms

NCT00005486 2016-02-18

Lymphangioleiomyomatosis (LAM) Registry

Completed

Lung Diseases, Lymphangioleiomyomatosis

NCT00014963 2006-03-23

Biomarkers of Benzene Exposure in Inner City Residents

Completed

90 enrolled

Lung Diseases, Neoplasms

NCT00041860 2005-06-24

Modulation of Benzene Metabolism by Exposure to Environment

Phase NA Completed

Lung Diseases, Neoplasms

Clinical Trials

Role of Genetic Factors in the Development of Lung Disease

Study of the Disease Process of Lymphangioleiomyomatosis

Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases

A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies

Lymphangioleiomyomatosis (LAM) Registry

Biomarkers of Benzene Exposure in Inner City Residents

Modulation of Benzene Metabolism by Exposure to Environment